Scientific Online Resource System

Scripta Scientifica Medica

Antibiotic-resistant acne vulgaris treated with oral isotretinoin in a patient with thalassemia minor

Vessela Raykova

Abstract

Acne vulgaris is very common among adolescents and young adults. Permanent scarring, poor self-image, depression, and anxiety can result from it. The acne treatment options include topical therapies, systemic agents, physical modalities, lasers, photodynamic therapy or combinations. Oral isotretinoin is widely recognised as a very effective treatment for severe acne. However, it may cause adverse effects.

We report a case of an 18-year-old man affected by thalassemia minor treated with oral isotretinoin because of a severe form of acne unresponsive to conventional oral antibiotic therapy. During the treatment clinical and biochemical evaluations were closely monitored each month in order to discover potential adverse effects of isotretinoin and the impact over thalassemia. After 9 months of oral isotretinoin application we can tell that the drug was well tolerated by the patient, the acne totally cleared, and the thalassemia did not deteriorate.

In conclusion, although a highly effective drug, isotretinoin use is limited by its side effects. However, patients may accept these procedures to improve the psychosocial effects of acne, because it can target all aspects of acne pathology. Something else, it is the choice of treatment in antibiotic-resistant forms of acne. It has been seen that the oral isotretinoin could be successfully used in patients with severe acne suffering from thalassemia minor in which the antibiotic treatment failed with the explicit requirement for strict clinical and biochemical follow-up.


Keywords

acne vulgaris, oral isotretinoin, thalassemia minor

Full Text


References

Klassen AF, Newton JN, Mallon E. Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J Am Acad Dermatol. 2000; 43(2 Pt 1):229-33. doi: 10.1067/mjd.2000.105507.

Dalgard F, Gieler U, Holm J, Bjertness E, Hauser S. Self-esteem and body satisfaction among late adolescents with acne: results from a population survey. J Am Acad Dermatol. 2008; 59(5):746-51. doi: 10.1016/j.jaad.2008.07.013.

Yazici K, Baz K, Yazici AE, Köktürk A, Tot S, Demirseren D, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol. 2004; 18(4):435-9. doi: 10.1111/j.1468-3083.2004.00946.x.

Marson JW, Baldwin HE. An overview of acne therapy, part 2: Hormonal therapy and isotretinoin. Dermatol Clin. 2019; 37(2):195-203. doi: 10.1016/j.det.2018.12.002.

Stangeland KZ, Huldt-Nystrøm T, Li X, Danielsen K. Treatment of acne. Tidsskr Nor Laegeforen. 2019; 139(12). doi: 10.4045/tidsskr.18.0946.

Leyden JJ, Rosso JQ, Baum EW. The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. J Clin Aesthet Dermato. 2014; 7(2 Suppl):S3‐21.

Layton AM. Disorders of sebaceous glands. In: Burns T, Breathnach S, Cox N, Griffiths C editor(s). Rook's Textbook of Dermatology. 8th Edition. Vol. 2, Oxford: Blackwell Publishing; 2010. pp. 38‐66.

Cyrulnik AA, Viola KV, Gewirtzman AJ, Cohen SR. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life. Int J Dermatol. 2012; 51(9):1123-30. doi: 10.1111/j.1365-4632.2011.05409.x.

Zouboulis CC, Bettoli V. Management of severe acne. Br J Dermatol. 2015; 172(Suppl 1):27-36. doi: 10.1111/bjd.13639.

Bettoli V , Borghia A, Pizzigoni S, De Sanctis V, Virgili A. Oral isotretinoin for severe acne in beta-thalassemia major. Dermatol. 2004; 208(4):360–1. doi: 10.1159/000077853.

Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol. 2001; 45(5):S150–7. doi: 10.1067/mjd.2001.113717

McLane J. Analysis of common side effects of isotretinoin. J Am Acad Dermatol. 2001; 45(5):S188–94. doi: 10.1067/mjd.2001.113719.

W Sinclair. Guidelines for the management of acne vulgaris. South Af Fam Pract. 2017; 59(1):24-9.

Nast A, Dréno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, et al. European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version. J Eur Acad Dermatol Venereol. 2016; 30(8):1261-8. doi: 10.1111/jdv.13776.




DOI: http://dx.doi.org/10.14748/ssm.v52i2.6426

Refbacks

About The Author

Vessela Raykova
Department of Medical Microbiology, Medical University-Sofia
Bulgaria

Font Size


|